Lariago 64.5 Injection 2ml is a prescription drug, available for use as Injection. Malaria are some of its major therapeutic uses.
The right dosage of Lariago 64.5 Injection 2ml depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Lariago 64.5 Injection 2ml side effects, there are can be others also. These have been listed below. Usually, these side effects of Lariago 64.5 Injection 2ml go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Lariago 64.5 Injection 2ml has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Lariago 64.5 Injection 2ml's effects on the liver, heart and kidney are discussed below in the Lariago 64.5 Injection 2ml related warnings section.
Lariago 64.5 Injection 2ml can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Lariago 64.5 Injection 2ml in conditions like Porphyria. Some other conditions that can be affected by Lariago 64.5 Injection 2ml are listed in the contraindications section below.
Drug interactions for Lariago 64.5 Injection 2ml have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Lariago 64.5 Injection 2ml is not safe while driving, and is is not addictive in nature.
Lariago 64.5 Injection 2ml is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Lariago 64.5 Injection 2ml safe for pregnant women?
Lariago has many dangerous side effects in pregnant women. If you are pregnant, do not consume Lariago without medical advice.
Is the use of Lariago 64.5 Injection 2ml safe during breastfeeding?
Taking Lariago may lead to serious side effects if you are breastfeeding. Lariago should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Lariago 64.5 Injection 2ml on the Kidneys?
Lariago can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Lariago 64.5 Injection 2ml on the Liver?
Lariago can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Lariago 64.5 Injection 2ml on the Heart?
The heart can be affected by Lariago. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Lariago 64.5 Injection 2ml should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lariago 64.5 Injection 2ml unless your doctor advises you to do so -
Is this Lariago 64.5 Injection 2ml habit forming or addictive?
Forming a habit of Lariago 64.5 Injection 2ml has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Lariago 64.5 Injection 2ml can make you feel drowsy.
Is it safe?
Yes, Lariago 64.5 Injection 2ml is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Lariago 64.5 Injection 2ml for mental disorders.
Interaction between Food and Lariago 64.5 Injection 2ml
Due to the absence of research, it is difficult to say how Lariago 64.5 Injection 2ml and food will interact.
Interaction between Alcohol and Lariago 64.5 Injection 2ml
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Lariago 64.5 Injection 2ml.
Yes, Lariago can be taken with diclofenac. No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking this drug do not hesitate to inform your doctor.
Yes, Lariago can affect blood sugar levels. It has been reported to lower the blood sugar levels (hypoglycemia). So, if you have diabetes keep a check on your blood sugar levels and in case if you feel lightheadedness, shaking or increased heartbeat after taking this drug then drink a glass of fruit juice, eat candies to restore your blood sugar levels and report to your doctor.
Rarely, Lariago causes hair loss (alopecia). This problem goes away after discontinuation of this drug. For partial hair loss, you are advised to use hair tonic and discuss with the doctor for best possible treatment to hair loss.
Take Lariago as directed by your doctor. Do not take this medicine longer than prescribed to avoid unpleasant side effects.
Lariago is a brand name of chloroquine and it comes in the form of a tablet, capsule, injection, and oral suspension. It belongs to the class of drugs known as antimalarials which have amebicidal activity. It is a prescription drug that is used in the treatment of malaria which is a vector-borne infectious disease caused by parasites Plasmodium species. These are Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodium vivax. Apart from this Lariago is also used in the treatment of extraintestinal amebiasis which is the protozoal infection caused by parasite Entamoeba histolytica. It is also used in the treatment of rheumatoid arthritis and systemic lupus erythematosus (SLE) both are autoimmune diseases which causes inflammation and pain. Lariago is also used off-label for the treatment of porphyria cutanea tarda (PCT) a blood disorder that affects the skin.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. Package leaflet information for the user; Aralen® Chloroquine phosphate. Eighth Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2019
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 211